News

In 2018, we have attended several expert committees of provincial, national and international scope in multiple therapeutic areas including oncology, and on new innovative drugs and challenges related to scientific assessment, economy and market access.

We attended the Annual meeting of the Association Québécoise des Pharmaciens Propriétaires (AQPP) in Quebec.

Presentation at La Corpo, an association of group insurance brokers, on Quebec and Canada drug evaluation processes and on pharmacoeconomics.

Our online continuous training program on optimal drug use, USOP Rx, available on usoprx.com, already counts 14 hours of training on evaluation processes in the province of Quebec as well as on many innovative drugs which have received recent public recommendations.

We attended the CADTH symposium in Halifax.

We attended the “Montreal Day 2018 – Navigating the New World of Oncology Reimbursement” symposium by the Canadian Association for Healthcare Reimbursement (CAHSP/CAHR).

Teacher of a pharmacoeconomics course offered to pharmacy students at Université Laval

Great news! Our new division is now launched. USOP Rx is a leading continuing education platform regarding pharmacoeconomic evaluation and optimal drug use for health and drug industry professionals.

Come visit us on usoprx.com

https://usoprx.com/une-premiere-plateforme-sur-levaluation-pharmacoeconomique-et-lusage-optimal-des-medicaments-pour-les-professionnels-de-la-sante/

We are proud to have participated, in March 2017, in a Harvard University training program to increase our negotiation skills and to broaden our range of strategies in order to optimize our service offering regarding the negotiation of drug listing agreements. Contact us for further details!

We attended the “Market Access 201: Parallel or Intersecting Paths – Future of Public and Private Reimbursement in Canada” symposium by the Canadian Association for Healthcare Reimbursement (CAHSP/CAHR)